Piedmont Investment Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-24,804
Closed -$1.18M 623
2020
Q1
$1.18M Buy
24,804
+2,236
+10% +$112K 0.05% 278
2019
Q4
$1.24M Sell
22,568
-2,076
-8% -$109K 0.04% 295
2019
Q3
$1.21M Sell
24,644
-924
-4% -$46.3K 0.05% 277
2019
Q2
$1.33M Buy
25,568
+10,632
+71% +$536K 0.05% 268
2019
Q1
$741K Buy
14,936
+168
+1% +$7.56K 0.03% 374
2018
Q4
$534K Buy
14,768
+4,008
+37% +$167K 0.03% 438
2018
Q3
$549K Buy
+10,760
New +$477K 0.02% 479

Other funds holding TECH

Piedmont Investment Advisors's TECH Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Bio-Techne (TECH) in Q2 2020, closing a stake of 24,804 shares — an estimated $1.18M sold.

Piedmont Investment Advisors first reported a position in TECH in Q3 2018 and held it in 7 quarters. The position peaked at $1.33M in Q2 2019. 392 funds tracked by Wall St. Rank hold TECH as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Bio-Techne position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 24,804 Bio-Techne shares in Q2 2020, an estimated $1.18M.
  • Piedmont Investment Advisors first reported a position in Bio-Techne in Q3 2018 and held it in 7 quarters.
  • Piedmont Investment Advisors's Bio-Techne position peaked at $1.33M in Q2 2019.
  • 392 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.